Notable
SMP-656 for HER2-Positive Advanced Breast Cancer
Recruitment opened
Chengdu SciMount Pharmatech Co., Ltd.Phase 2 NCT07726342 Registry history of NCT07726342 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Recruitment opened
Chengdu SciMount Pharmatech Co., Ltd.Phase 2 NCT07726342 Registry history of NCT07726342 on ClinicalTrials.gov (opens the registry)
| Phase 2 | 1 |
Breast Cancer (1) · HER2-Positive Cancer (1)